1 | S. Altaf, M. Zeeshan, H. Ali, A. Zeb, I. Afzal, A. Imran, D. Mazhar, and S. Khan, “pH-sensitive tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 204, p. 114461, 2024. | 2024 |
2 | Q. U. Ain, M. Zeeshan, D. Mazhar, A. Zeb, I. Afzal, H. Ullah, H. Ali, A. Rahdar, and A. M. D´ıez-Pascual, “QbD-based fabrication of biomimetic hydroxyapatite embedded gelatin nanoparticles for localized drug delivery against deteriorated arthritic joint architecture,” Macromolecular Bioscience, vol. 24, no. 2, p. 2300336, 2024. | 2024 |
3 | G. Mustafa, D. Hassan, M. Zeeshan, G. Ruiz-Pulido, N. Ebrahimi, A. Mobashar, M. Pourmadadi, A. Rahdar, S. Sargazi, S. Fathi-karkan et al., “Advances in nanotechnology versus stem cell therapy for the theranostics of huntington’s disease,” Journal of Drug Delivery Science and Technology, vol. 87, p. 104774, 2023. | 2023 |
4 | S. Fathi-karkan, M. Zeeshan, M. Qindeel, R. E. Malekshah, A. Rahdar, and L. F. R. Ferreira, “NPs loaded with zoledronic acid as an advanced tool for cancer therapy,” Journal of Drug Delivery Science and Technology, vol. 87, p. 104805, 2023. | 2023 |
5 | M. Zeeshan, Q. U. Ain, B. Weigmann, D. Story, B. R. Smith, and H. Ali, “Dual pH and microbial-sensitive galactosylated polymeric nanocargoes for multi-level targeting to combat ulcerative colitis,” Asian Journal of Pharmaceutical Sciences, vol. 18, no. 4, p. 100831, 2023. | 2023 |
6 | D. Mazhar, N. U. Haq, M. Zeeshan, Q. U. Ain, H. Ali, S. Khan, and S. A. Khan, “Preparation, characterization, and pharmacokinetic assessment of metformin hcl loaded transfersomes co-equipped with permeation enhancer to improve drug bioavailability via transdermal route,” Journal of Drug Delivery Science and Technology, vol. 84, p. 104448, 2023. | 2023 |
7 | M. Zeeshan, Q. U. Ain, A. Sunny, F. Raza, M. Mohsin, S. Khan, B. Weigmann, and H. Ali, “Qbd-based fabrication of transferrin-anchored nanocarriers for targeted drug delivery to macrophages and colon cells for mucosal inflammation healing,” Biomaterials Science, vol. 11, no. 4, pp. 1373–1397, 2023. | 2023 |
8 | K. Lechner, M. Zeeshan, M. Noack, H. Ali, M. F. Neurath, and B. Weigmann, “Small but powerful: will nanoparticles be the future state-of-the-art therapy for ibd?” Expert Opinion on Drug Delivery, vol. 19, no. 3, pp. 235–245, 2022. | 2022 |
9 | E. Sana, M. Zeeshan, Q. U. Ain, A. U. Khan, I. Hussain, S. Khan, E. Lepeltier, and H. Ali, “Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting nf-κβ pathway,” Nanomedicine, vol. 16, no. 10, pp. 819–837, 2021. | 2021 |
10 | F. Sabir, M. Zeeshan, U. Laraib, M. Barani, A. Rahdar, M. Cucchiarini, and S. Pandey, “Dna based and stimuli-responsive smart nanocarrier for diagnosis and treatment of cancer: Applications and challenges,” Cancers, vol. 13, no. 14, p. 3396, 2021. | 2021 |
11 | M. Barani, M. Zeeshan, D. Kalantar-Neyestanaki, M. A. Farooq, A. Rahdar, N. K. Jha, S. Sargazi, P. K. Gupta, and V. K. Thakur, “Nanomaterials in the management of gram-negative bacterial infections,” Nanomaterials, vol. 11, no. 10, p. 2535, 2021. | 2021 |
12 | F. Sabir, M. Qindeel, M. Zeeshan, Q. Ul Ain, A. Rahdar, M. Barani, E. Gonz´alez, and M. A. Aboudzadeh, “Onco-receptors targeting in lung cancer via application of surface-modified and hybrid nanoparticles: A cross-disciplinary review,” Processes, vol. 9, no. 4, p. 621, 2021. | 2021 |
13 | M. Zeeshan, A. Atiq, Q. U. Ain, J. Ali, S. Khan, and H. Ali, “Evaluating the mucoprotective effects of glycyrrhizic acid-loaded polymeric nanoparticles in a murine model of 5-fluorouracil-induced intestinal mucositis via suppression of inflammatory mediators and oxidative stress,” Inflammopharmacology, vol. 29, pp. 1539–1553, 2021. | 2021 |
14 | M. Zeeshan, H. Ali, Q. U. Ain, M. Mukhtar, R. Gul, A. Sarwar, and S. Khan, “A holistic qbd approach to design galactose conjugated plga polymer and nanoparticles to catch macrophages during intestinal inflammation,” Materials Science and Engineering: C, vol. 126, p. 112183, 2021. | 2021 |
15 | M. Barani, M. Reza Hajinezhad, S. Sargazi, M. Zeeshan, A. Rahdar, S. Pandey, M. Khatami, and F. Zargari, “Simulation, in vitro, and in vivo cytotoxicity assessments of methotrexate-loaded ph-responsive nanocarriers,” Polymers, vol. 13, no. 18, p. 3153, 2021. | 2021 |
16 | M. Mukhtar, E. F´enyes, C. Bartos, M. Zeeshan, and R. Ambrus, “Chitosan biopolymer, its derivatives and potential applications in nano-therapeutics: A comprehensive review,” European Polymer Journal, vol. 160, p. 110767, 2021. | 2021 |
17 | M. Mukhtar, M. Zesshan, S. Khan, G. Shahnaz, S. A. Khan, H. S. Sarwar, R. A. Pasha, and H. Ali, “Fabrication and optimization of ph-sensitive mannose-anchored nano-vehicle as a promising approach for macrophage uptake,” Applied Nanoscience, vol. 10, pp. 4013–4027, 2020 | 2020 |
18 | M. Mukhtar, E. Pallagi, I. Cs´oka, E. Benke, ´A. Farkas, M. Zeeshan, K. Buri´an, D. K´okai, and R. Ambrus, “Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex dpis as a potential tb treatment,” International Journal of Biological Macromolecules, vol. 165, pp. 3007–3019, 2020. | 2020 |
19 | M. Zeeshan, H. Ali, S. Khan, S. A. Khan, and B. Weigmann, “Advances in orally-delivered ph-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease,” International journal of pharmaceutics, vol. 558, pp. 201–214, 2019. | 2019 |
20 | M. Zeeshan, H. Ali, S. Khan, M. Mukhtar, M. I. Khan, and M. Arshad, “Glycyrrhizic acid-loaded ph-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease,” Nanomedicine, vol. 14, no. 15, pp. 1945–1969, 2019. | 2019 |
21 | Q. Ain, M. Zeeshan, S. Khan, and H. Ali, “Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis,” Journal of Biomedical Materials Research Part A, vol. 107, no. 12, pp. 2595–2600, 2019. | 2019 |